Ciardiello F, Kim N, Saeki T, Dono R, Persico M G, Plowman G D, Garrigues J, Radke S, Todaro G J, Salomon D S
Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7792-6. doi: 10.1073/pnas.88.17.7792.
Amphiregulin (AR) and cripto are proteins that are structurally related to epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha). AR is also functionally related to this family of growth regulatory molecules and is able to bind and activate the 170-kDa EGF receptor (EGFR). Human EGFR-3 (HER3)/ERBB3 is a recently identified protein related to the EGFR that is widely expressed in breast carcinomas and is a candidate receptor for EGF-like growth factors. Differential expression of these putative ligands and receptors in transformed cells suggests that they may function in an autocrine manner to regulate tumor cell growth. Specific mRNA transcripts for TGF-alpha [4.8 kilobases (kb)], AR (1.4 kb), cripto (2.2 kb), and HER3 (6.2 kb) were expressed in a majority of human colon cancer cell lines. HER3 mRNA was detected in 55% of primary or metastatic human colorectal carcinomas but in only 22% of normal colon mucosa and 32% of normal liver samples. In contrast, cripto and AR mRNA were expressed in 60-70% of primary or metastatic human colorectal cancers but in only 2-7% of normal human colonic mucosa. Immunostaining also detected AR protein in primary and metastatic colorectal tumors but not in normal colon or uninvolved liver. These findings suggest that cripto and AR may be useful markers to discriminate between normal and malignant colonic epithelium and may provide a selective growth advantage for colorectal carcinomas.
双调蛋白(AR)和cripto是在结构上与表皮生长因子(EGF)和转化生长因子α(TGF-α)相关的蛋白质。AR在功能上也与这个生长调节分子家族相关,并且能够结合并激活170-kDa的EGF受体(EGFR)。人EGFR-3(HER3)/ERBB3是最近发现的一种与EGFR相关的蛋白质,在乳腺癌中广泛表达,是EGF样生长因子的候选受体。这些假定的配体和受体在转化细胞中的差异表达表明它们可能以自分泌方式发挥作用来调节肿瘤细胞的生长。TGF-α[4.8千碱基(kb)]、AR(1.4 kb)、cripto(2.2 kb)和HER3(6.2 kb)的特异性mRNA转录本在大多数人结肠癌细胞系中表达。在55%的原发性或转移性人结肠直肠癌中检测到HER3 mRNA,但在仅22%的正常结肠黏膜和32%的正常肝脏样本中检测到。相反,cripto和AR mRNA在60-70%的原发性或转移性人结肠直肠癌中表达,但在仅2-7%的正常人结肠黏膜中表达。免疫染色也在原发性和转移性结肠肿瘤中检测到AR蛋白,但在正常结肠或未受累的肝脏中未检测到。这些发现表明cripto和AR可能是区分正常和恶性结肠上皮的有用标志物,并且可能为结肠直肠癌提供选择性生长优势。